Samrat Pharmachem Ltd.
| BSE: 530125 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE103E01016 |
| BSE 00:00 | 26 Feb | 149.00 |
3.40 (2.34%) |
OPEN
145.00 |
HIGH
149.95 |
LOW
141.55 |
| NSE 05:30 | 01 Jan | Samrat Pharmachem Ltd |
| OPEN | 145.00 |
| PREVIOUS CLOSE | 145.60 |
| VOLUME | 12224 |
| 52-Week high | 159.00 |
| 52-Week low | 47.10 |
| P/E | 11.05 |
| Mkt Cap.(Rs cr) | 46 |
| Buy Price | 149.00 |
| Buy Qty | 17.00 |
| Sell Price | 149.90 |
| Sell Qty | 100.00 |
Samrat Pharmachem Ltd. (SAMRATPHARMA) - Company Information
Samrat Pharmachem Ltd
Samrat Pharmachem Ltd is planning to de-merge its Second Unit in favour of newly formed company viz. Samrat Remedies Ltd w.e.f. April 1 2004....> More
| COMPANY INFORMATION | |||||||
| Chairman & Managing Director : | Lalit Mehta | ||||||
| Director & CFO : | Rajesh Mehta | ||||||
| Independent Director : | Mahendra Pipalia | ||||||
| Independent Director : | Samir Kothary | ||||||
| Independent Director : | Renu P Dharod | ||||||
| Director : | Megh Mehta | ||||||
| Company Secretary : | Nishant Kankaria | ||||||
| AUDITOR : | Shah & Savla LLP | ||||||
| IND NAME : | Pharmaceuticals - Indian - Bulk Drugs | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| Plot No A2/3445, GIDC Phase IV,Ankleshwar,Gujarat-393002 | |||||||
| Ph : 91-2646-220774 | |||||||
| WEBSITE : http://www.samratpharmachem.com | |||||||
| E-mail : samrat@bom4.vsnl.net.in | |||||||
Quick Links for Samrat Pharmachem:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
